Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?
Open Access
- 14 April 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (6) , e851-e860
Abstract
Diabetic kidney disease (DKD) is the leading cause of CKD and ESKD in the United States and worldwide. Pharmacotherapy and lifestyle modifications for glycemia, dyslipidemia, and BP control have shown success in slowing the progression of DKD. Traditional treatments, such as angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and more recently the use of sodium-glucose cotransporter 2 inhibitors, nonsteroidal selective mineralocorticoid receptor antagonists, such as finerenone, and glucagon-like peptide 1 receptor agonists, have led to added benefits on various outcomes. However, significant residual risk for DKD progression remains despite the current standard-of-care approaches. Arteriolar hyalinosis (AH) is among the key findings seen on kidney biopsies of patients with DKD. It results from the excessive accumulation of hyaluronan (HA) in the arterioles. AH has not been targeted specifically by any of the therapeutic methods currently being used. We discuss in this manuscript the potential use of a selective therapy targeting AH and the increased total renal HA deposits using a HA synthesis inhibitor in DKD.Keywords
This publication has 70 references indexed in Scilit:
- Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trialBMC Medicine, 2013
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 DiabetesNew England Journal of Medicine, 2011
- Inhibition of Hyaluronan Synthesis Accelerates Murine AtherosclerosisCirculation, 2010
- Renal autoregulation and passive pressure-flow relationships in diabetes and hypertensionAmerican Journal of Physiology-Renal Physiology, 2010
- 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3Experimental Cell Research, 2009
- Exenatide-Associated Ischemic Renal FailureDiabetes Care, 2009
- Overexpression of Hyaluronan in the Tunica Media Promotes the Development of AtherosclerosisCirculation Research, 2005
- Comparisons of Detections, Stabilities, and Kinetics of Degradation of Hymecromone and Its Glucuronide and Sulfate MetabolitesJournal of Pharmaceutical Sciences, 1994
- Impaired autoregulation of cerebral blood flow in long‐term Type I (insulin‐dependent) diabetic patients with nephropathy and retinopathyClinical Physiology and Functional Imaging, 1986
- Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes I. Development of initial basement membrane thickeningDiabetologia, 1972